Chorionic villus sampling is a prenatal diagnostic test performed for prenatal genetic testing involving a biopsy of placental tissue between 10 to 13 weeks gestation. The tissue harvested is the ...

The risk of miscarriage after undergoing chorionic villus sampling, or CVS, to detect birth defects is lower than previously thought and essentially carries the same risk as the more commonly used ...

Noninvasive prenatal testing detected 83.2 percent of chromosomal abnormalities normally picked up by invasive diagnostic testing strategies, such as chorionic villus sampling or amniocentesis. In a ...

Researchers in the Netherlands believe they are on the verge of developing a simple, prenatal blood test that would be able to detect accurately chromosomal abnormalities in the developing fetus. At ...

Please provide your email address to receive an email when new articles are posted on . The mean maternal age at first birth has been increasing in the United States in recent years, from 24.9 years ...

As with amniocentesis, obstetricians may suggest using CVS, short for chorionic villus sampling, to detect genetic disorders such as Down Syndrome. In CVS, specialists perform an ultrasound to ...

The definitive diagnosis of fetal aneuploidy and genomic imbalances requires invasive collection of fetal cells through amniocentesis or chorionic villus sampling. These methods are associated with ...

A research team from Odense University Hospital and the University of Southern Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize ...

Our team of maternal-fetal medicine specialists and prenatal genetic counselors have extensive training and experience in prenatal genetic testing. Providers throughout the Mountain West regularly ...

Trophoblasts, cells present during development in the fetus and placenta that also circulate in a pregnant woman’s bloodstream, could potentially be used for noninvasive prenatal diagnosis, according ...

In 2009, the California Genetic Disease Branch introduced an aneuploidy screening program allowing Medi-Cal (state insured) patients access to state-sponsored first-trimester screening. The objective ...